Abstract
Objective: The Borderline Symptom List (BSL-23) was developed to provide a relatively brief and objective measure of BPD symptomatology. This review aims to provide a synthesis of how the measure has been used in practice, with what populations, research questions and methodologies, and to review its known reliability across these populations.
Methods: A systematic review was conducted by searching relevant databases for studies which had used the BSL-23 with an adult BPD sample. Results were analysed narratively, and a meta-analysis of reported reliability coefficients was conducted.
Results: 29 studies comprising 3,492 participants were included. Most studies were conducted in Germany or Spain. Results indicated an overrepresentation of younger women. Notably, there is no evidence of a published validation of an English language version. Meta-analysis of Cronbach’s alpha suggests very high reliability, possibly hinting at a narrow conceptualisation of assessed symptoms.
Discussion: The BSL-23 remains a versatile tool. It has been applied in diverse settings for various purposes in a range of study designs. Clinicians and researchers need to be aware of the settings in which the BSL-23 has been used less frequently, with the current review making a number of recommendations for future research to fill the most important gaps.
Methods: A systematic review was conducted by searching relevant databases for studies which had used the BSL-23 with an adult BPD sample. Results were analysed narratively, and a meta-analysis of reported reliability coefficients was conducted.
Results: 29 studies comprising 3,492 participants were included. Most studies were conducted in Germany or Spain. Results indicated an overrepresentation of younger women. Notably, there is no evidence of a published validation of an English language version. Meta-analysis of Cronbach’s alpha suggests very high reliability, possibly hinting at a narrow conceptualisation of assessed symptoms.
Discussion: The BSL-23 remains a versatile tool. It has been applied in diverse settings for various purposes in a range of study designs. Clinicians and researchers need to be aware of the settings in which the BSL-23 has been used less frequently, with the current review making a number of recommendations for future research to fill the most important gaps.
| Original language | English |
|---|---|
| Journal | Clinical Psychologist |
| DOIs | |
| Publication status | Published - 9 Feb 2026 |
Keywords
- BPD
- BSL-23
- Borderline Personality Disorder
- Borderline Symptom List
- self-report measure
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver